tiprankstipranks
Brainsway Ltd (BRSYF)
OTHER OTC:BRSYF
US Market
Holding BRSYF?
Track your performance easily

Brainsway (BRSYF) Stock Price & Analysis

8 Followers

BRSYF Stock Chart & Stats


Financials

Annual

Ownership Overview

0.29%0.24%99.47%
Insiders
0.24% Other Institutional Investors
99.47% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

BRSYF FAQ

What was Brainsway Ltd’s price range in the past 12 months?
Brainsway Ltd lowest stock price was $1.85 and its highest was $3.15 in the past 12 months.
    What is Brainsway Ltd’s market cap?
    Currently, no data Available
    When is Brainsway Ltd’s upcoming earnings report date?
    Brainsway Ltd’s upcoming earnings report date is Apr 01, 2025 which is in 127 days.
      How were Brainsway Ltd’s earnings last quarter?
      Brainsway Ltd released its earnings results on Nov 12, 2024. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of N/A by $0.02.
        Is Brainsway Ltd overvalued?
        According to Wall Street analysts Brainsway Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Brainsway Ltd pay dividends?
          Brainsway Ltd does not currently pay dividends.
          What is Brainsway Ltd’s EPS estimate?
          Brainsway Ltd’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Brainsway Ltd have?
          Brainsway Ltd has 37,594,334 shares outstanding.
            What happened to Brainsway Ltd’s price movement after its last earnings report?
            Brainsway Ltd reported an EPS of $0.02 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Brainsway Ltd?
              Currently, no hedge funds are holding shares in BRSYF
              ---

              Brainsway Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Positive
              20 days / 200 days
              Momentum
              65.78%
              12-Months-Change

              Fundamentals

              Return on Equity
              3.52%
              Trailing 12-Months
              Asset Growth
              20.62%
              Trailing 12-Months

              Company Description

              Brainsway Ltd

              Brainsway Ltd. engages in the research, development and marketing of medical device for non-invasive treatment of the brain disorders. Its technology enables handling of a wide range of indications through the TMS Deep system developed by the company. Brainsway operates through the following segments: Major depression and Obsessive Compulsive Disorder (OCD). The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.
              ---

              BRSYF Earnings Call

              Q3 2024
              0:00 / 0:00
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              CNS Pharmaceuticals
              SELLAS Life Sciences Group
              TuHURA Biosciences
              Climb Bio
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis